Gene · 2923
Papers3,219
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 3,219
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unfolded protein response and angiogenesis in malignancies. | Biochim Biophys Acta Rev Cancer | 2023 | 36414127 | PubTator, text mining | PubMed |
| On target methods to induce abscopal phenomenon for Off-Target effects: From happenstance to happenings. | Cancer Med | 2023 | 36411943 | PubTator, text mining | PubMed |
| Engineered T cell therapy for viral and non-viral epithelial cancers. | Cancer Cell | 2023 | 36400016 | PubTator, text mining | PubMed |
| Protein disulfide isomerase A3 activity promotes extracellular accumulation of proteins relevant to basal breast cancer outcomes in human MDA-MB-A231 breast cancer cells. | Am J Physiol Cell Physiol | 2023 | 36374169 | PubTator, text mining | PubMed |
| Mechanism of exosomes in the tumor microenvironment in the abscopal effect (Review). | Int J Oncol | 2023 | 36367187 | PubTator, text mining | PubMed |
| Efficient Multiple Domain Ligation for Proteins Using Asparaginyl Endopeptidase by Selection of Appropriate Ligation Sites Based on Steric Hindrance. | Angew Chem Int Ed Engl | 2023 | 36347766 | PubTator, text mining | PubMed |
| HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation. | Cell Mol Gastroenterol Hepatol | 2023 | 36244648 | PubTator, text mining | PubMed |
| A comprehensive SARS-CoV-2-human protein-protein interactome reveals COVID-19 pathobiology and potential host therapeutic targets. | Nat Biotechnol | 2023 | 36217030 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Shc Is Implicated in Calreticulin-Mediated Sterile Inflammation in Alcoholic Hepatitis. | Cell Mol Gastroenterol Hepatol | 2023 | 36122677 | PubTator, text mining | PubMed |
| Proteomics research of SARS-CoV-2 and COVID-19 disease. | Med Rev (2021) | 2022 | 37724330 | PubTator, text mining | PubMed |
| Identification of key biomarkers and signaling pathways and analysis of their association with immune cells in immunoglobulin A nephropathy. | Cent Eur J Immunol | 2022 | 36817268 | PubTator, text mining | PubMed |
| Immunogenic cell death: The cornerstone of oncolytic viro-immunotherapy. | Front Immunol | 2022 | 36755812 | PubTator, text mining | PubMed |
| Quantitative proteomics and biological activity of extracellular vesicles engineered to express SARS-CoV-2 spike protein. | J Extracell Biol | 2022 | 36710959 | PubTator, text mining | PubMed |
| The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment. | Front Immunol | 2022 | 36703971 | PubTator, text mining | PubMed |
| Editorial: Novel biomarkers for anticancer therapy. | Front Pharmacol | 2022 | 36686681 | PubTator, text mining | PubMed |
| Integrated Profiles of Transcriptome and mRNA m6A Modification Reveal the Intestinal Cytotoxicity of Aflatoxin B1 on HCT116 Cells. | Genes (Basel) | 2022 | 36672820 | PubTator, text mining | PubMed |
| Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer. | Transl Androl Urol | 2022 | 36632166 | PubTator, text mining | PubMed |
| Spondyloarthritides: Theories and beyond. | Front Pediatr | 2022 | 36619518 | PubTator, text mining | PubMed |
| Multifaceted Pharmacological Potentials of Curcumin, Genistein, and Tanshinone IIA through Proteomic Approaches: An In-Depth Review. | Cancers (Basel) | 2022 | 36612248 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2923/papers?page=21